tyrosine has been researched along with axitinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brand-Saberi, B; Foehring, D; Theiss, C | 1 |
| Ali, DM; Balasubramaniyan, S; Irfan, N; Puratchikody, A | 1 |
2 other study(ies) available for tyrosine and axitinib
| Article | Year |
|---|---|
VEGF-induced growth cone enhancement is diminished by inhibiting tyrosine-residue 1214 of VEGFR-2.
Topics: Animals; Antibodies, Blocking; Axitinib; Axons; Blotting, Western; Cell Movement; Cells, Cultured; Chick Embryo; Chickens; Ganglia, Spinal; Growth Cones; Imidazoles; Indazoles; Mice; Microscopy, Confocal; Neurons; Protein Kinase Inhibitors; Signal Transduction; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2012 |
Bioisosteric replacements of tyrosine kinases inhibitors to make potent and safe chemotherapy against malignant cells.
Topics: Antineoplastic Agents; Axitinib; Protein-Tyrosine Kinases; Tyrosine | 2023 |